GLP-1 Receptor Agonists and Muscle Mass: Balancing Weight Loss and Lean Tissue Preservation
A 2025 review in Pharmacological Research explores metabolic benefits and lean mass changes during GLP-1 RA therapy. Findings suggest monitoring of vulnerable populations and adjunct strategies including resistance training and protein intake may mitigate lean tissue loss.
